The conflicting safety signal One real-world evidence study found that patients receiving GLP-1 receptor agonists had higher risks of certain autoimmune conditions, including ulcerative colitis, rheumatoid arthritis, autoimmune thyroiditis, ankylosing spondylitis, and psoriasis, compared to those on DPP-4 inhibitors
A return to category 1 means patients can once again access these compounds through legitimate, FDA-inspected channels under the guidance of experienced physicians
Compounded semaglutide costs significantly less than brand-name versions
Since KD naturally reduces hunger and drives energy deficits without calorie counting, it offers similar or greater weight-loss benefits as appetite-suppressing drugs or those that block fat absorption without documented adverse effects such as nausea and diarrhea
43 PGE2EP4 signaling has been shown to inhibit sympathetic outflow by promoting phosphorylation of cAMP response element-binding protein (CREB) in the hypothalamus, thereby facilitating osteogenesis by directing mesenchymal stromal cell (MSC) differentiation toward the osteoblastic lineage
